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ABSTRACT The import of nonnatural molecules is a recurring problem in funda-
mental and applied aspects of microbiology. The dipeptide permease (Dpp) of
Escherichia coli is an ABC-type multicomponent transporter system located in the
cytoplasmic membrane, which is capable of transporting a wide range of di- and
tripeptides with structurally and chemically diverse amino acid side chains into
the cell. Given this low degree of speciﬁcity, Dpp was previously used as an en-
try gate to deliver natural and nonnatural cargo molecules into the cell by at-
taching them to amino acid side chains of peptides, in particular, the -carboxyl
group of glutamate residues. However, the binding afﬁnity of the substrate-bind-
ing protein dipeptide permease A (DppA), which is responsible for the initial
binding of peptides in the periplasmic space, is signiﬁcantly higher for peptides
consisting of standard amino acids than for peptides containing side-chain modi-
ﬁcations. Here, we used adaptive laboratory evolution to identify strains that uti-
lize dipeptides containing -substituted glutamate residues more efﬁciently and
linked this phenotype to different mutations in DppA. In vitro characterization of
these mutants by thermal denaturation midpoint shift assays and isothermal
titration calorimetry revealed signiﬁcantly higher binding afﬁnities of these vari-
ants toward peptides containing -glutamyl amides, presumably resulting in im-
proved uptake and therefore faster growth in media supplemented with these
nonstandard peptides.
IMPORTANCE Fundamental and synthetic biology frequently suffer from insufﬁcient
delivery of unnatural building blocks or substrates for metabolic pathways into bac-
terial cells. The use of peptide-based transport vectors represents an established
strategy to enable the uptake of such molecules as a cargo. We expand the scope of
peptide-based uptake and characterize in detail the obtained DppA mutant variants.
Furthermore, we highlight the potential of adaptive laboratory evolution to identify
beneﬁcial insertion mutations that are unlikely to be identiﬁed with existing directed
evolution strategies.
KEYWORDS peptide transport, portage transport, -glutamyl transferase, membrane
transport, isothermal titration calorimetry, adaptive laboratory evolution, substrate
speciﬁcity, ABC transporters, synthetic biology, dipeptide permease, gamma-glutamyl
transferase
Transport across membranes is an often-undervalued factor that frequently limitsmetabolic engineering or synthetic biology approaches due to insufﬁcient uptake
of potentially interesting molecules (1). Several approaches to develop broadly appli-
cable solutions to overcome limitations in membrane transport have been presented
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during the last decades, most of them using peptides as transport vectors and taking
advantage of the low substrate speciﬁcity of peptide transporters. It was previously
reported that cargo molecules can be delivered into the cell by attaching them to the
N or C termini or speciﬁc amino acid side chains of di- or tripeptides, from where they
would eventually be released inside the cell by endogenous peptidases or chemical
decomposition of the transport vector-cargo construct (2–8). We recently presented a
synthetic transport system that enables the uptake of cargo molecules into Escherichia
coli by attaching them via a stable amide linkage to the -carboxyl group of a
glutamate residue of the dipeptide alanyl-glutamate (Ala-Glu) (9). Once the peptide
harboring the -glutamyl amide has been taken up, the N-terminal alanine residue is
removed by intracellular peptidases, and the liberated -glutamyl amide is further
hydrolyzed by a cytoplasmic variant of the enzyme -glutamyl transferase from Pseu-
domonas nitroreducens (PnGGT) to release the cargo molecule inside the cell. With this
system, we were able to demonstrate the uptake of different natural and nonnatural
cargo molecules, offering a more general and potentially versatile approach to over-
come transport problems in E. coli.
Clearly, the versatility of the system depends largely on the substrate speciﬁcity of
the bacterial peptide importers, which belong to the class of ATP-binding cassette
(ABC) transporters. ABC transporters are multisubunit transporters that play a funda-
mental role in regulation of the uptake of nutrients into and the secretion of toxic or
harmful compounds out of the cell (10). Most of them evolved to be highly specialized
for the transport of a single compound or small groups of structurally similar com-
pounds across membranes. Corresponding to this high degree of speciﬁcity, bacteria
have developed a broad spectrum of ABC transporters to deal with the import of a
broad range of different compounds (11). In E. coli, ABC transporters are the largest
paralogous protein family, with their genes occupying approximately 5% of the E. coli
genome (12). ABC transporters are usually composed of two transmembrane proteins
that form a membrane channel and two nucleotide-binding proteins that generate
energy for the translocation process by hydrolyzing ATP on the cytoplasmic side of the
membrane. Additionally, ABC transporters often have soluble substrate-binding pro-
teins (SBPs) that capture their substrates in the periplasmic space of Gram-negative or
the extracellular space of Gram-positive bacteria and deliver them to their respective
transmembrane proteins.
The E. coli peptide transporters dipeptide permease (DppABCDF) and oligopeptide
permease (OppABCDF) are the main uptake routes for peptides from the environment
and are known to have rather relaxed substrate speciﬁcities (13). Dipeptide permease
has a preference for dipeptides and only little afﬁnity for certain tripeptides (14, 15).
Oligopeptide permease, on the other hand, prefers tripeptides but can transport larger
peptides up to hexapeptides with reduced efﬁciency (16–18). To be transported by the
dipeptide or oligopeptide permease transport systems, peptides have to be captured
in the periplasmic space by the non-membrane-attached SBPs DppA or OppA, which,
to a large extent, determine the substrate speciﬁcities of their transporters (19, 20). Both
SBPs possess large water-ﬁlled binding pockets that can accommodate peptides with
structurally diverse amino acid side chains, thereby contributing to the low substrate
speciﬁcity of the two transporters (21, 22). Despite this rather low degree of speciﬁcity,
it was demonstrated that DppA is less tolerant toward peptides with side-chain
modiﬁcations than OppA (23).
In this study, we aimed to investigate the uptake of peptides containing -substituted
glutamate residues in more detail in view of possible expansions of the uptake
spectrum, using an experimental system for which we assume that the uptake of
suitable substrates is the limiting factor in the complementation of growth auxotro-
phies. Mutations in the periplasmic SBP DppA that led to improved utilization of these
peptides were identiﬁed by adaptive laboratory evolution. Characterization of the
DppA variants by thermal denaturation midpoint shift assays and isothermal titration
calorimetry (ITC) conﬁrmed that the mutations had indeed increased the binding
afﬁnity toward peptides containing -glutamyl amides. The results obtained in
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this study constitute a signiﬁcant improvement in our previously described synthetic
transport system.
RESULTS
Identiﬁcation of transporters involved in Ala--Glu-Leu uptake. We previously
reported that the peptide Ala--Glu-Leu (Fig. 1a, peptide 1), an Ala-Glu dipeptide with
a leucine attached to the -carboxyl group of Glu, can be taken up by E. coli and used
as sole source of leucine, provided that the leucine residue is released intracellularly
from the glutamate side chain by a cytoplasmic variant of the enzyme PnGGT (9). To
analyze the uptake of Ala--Glu-Leu in more detail, we aimed to identify the uptake
route of this peptide. For this, the dppABCDF and oppABCDF operons, encoding the
versatile dipeptide and oligopeptide permease transport systems, respectively, were
deleted in the leucine auxotrophic selection strain TK070 (see Table 4), resulting in
strains TK071 (ΔdppABCDF), TK072 (ΔoppABCDF), and TK073 (ΔdppABCDF ΔoppABCDF).
All strains were transformed with plasmid pPnGGT to synthesize the cytoplasmic PnGGT
variant, and the resulting strains were tested for growth on plates containing M9
minimal medium supplemented with glucose and the peptide Ala--Glu-Leu (1 mM) as
the sole source of leucine (Fig. 1b). Only the two strains carrying a deletion in the
dppABCDF operon were unable to grow on this medium, indicating that the peptide
Ala--Glu-Leu is exclusively taken up via the Dpp dipeptide permease transport system.
FIG 1 Uptake of dipeptides containing -substituted glutamates. (a) The following peptides were used in this study: Ala--Glu-Leu (1), Ala--Glu-Phe-Leu (2),
Ala--Glu-O-phospho-L-serine (SEP) (3), and Ala--Glu-O-phospho-L-homoserine (PHS) (4). The respective cargoes of the peptides are highlighted in yellow. (b)
The leucine auxotrophic selection strains TK070, TK071, TK072, and TK073 were transformed with pPnGGT and reisolated on plates containing M9 minimal
medium supplemented with 0.5% glucose, 0.5 mM IPTG, and 1 mM Ala--Glu-Leu. The plate was incubated for 2 days at 37°C. (c) Strain TK070/pPnGGT was
transformed with the plasmids pSEVA271 (empty vector), pSEVA271/dppA (synthesizing DppA), pSEVA271/dppA_S268L (DppA S268L), pSEVA271/
dppA_D395dup (DppA D395dup), and pSEVA271/dppA_S268L_D395dup (DppA S268L D395dup). (c to e) Growth was tested in liquid M9 minimal medium
supplemented with 0.5% glucose, 0.5 mM IPTG, 100 ng · ml1 anhydrotetracycline, and 0.1 mM (c), 0.25 mM (d), or 0.5 mM (e) the peptide Ala--Glu-Leu. (f)
Similar growth experiment in liquid M9 minimal medium supplemented with 0.5% glucose, 0.5 mM IPTG, 100 ng · ml1 anhydrotetracycline, and 2 mM the
peptide Ala--Glu-Phe-Leu. Error bars in the growth curves represent the standard deviation from 3 replicates.
Mutants of Dipeptide-Binding Protein DppA Applied and Environmental Microbiology
July 2018 Volume 84 Issue 13 e00340-18 aem.asm.org 3
 o
n
 July 4, 2018 by BIO
ZENTRUM
 DER UNIV BASEL
http://aem
.asm
.org/
D
ow
nloaded from
 
Adaptive laboratory evolution to improve utilization of Ala--Glu-Leu. The
growth of strain TK070/pPnGGT was restored in minimal medium supplemented with
glucose and 1 mM Ala--Glu-Leu but was hardly detectable if peptide concentrations
were lower than 0.5 mM. These concentrations are relatively high compared to the
concentrations of free leucine or leucine-containing peptides that are required at
approximately 0.1 to 0.4 mM to restore growth of a leucine auxotrophic E. coli strain
(24), which indicates inefﬁciencies in uptake or intracellular processing of Ala--Glu-Leu.
To improve growth at low concentrations of this peptide, adaptive laboratory evolution
experiments were performed. Adaptive laboratory evolution is a method to accumulate
evolutionary changes in microbial populations during long-term selection under spec-
iﬁed growth conditions (25). For this, leucine auxotrophic strain TK070 was freshly
transformed with pPnGGT and plated on a plate containing M9 minimal medium
supplemented with 0.5% glucose, 0.5 mM isopropyl--D-thiogalactopyranoside (IPTG),
and only 0.1 mM Ala--Glu-Leu. After a 10-day incubation period at 37°C, the formation
of small colonies was detected, and the adaptive phenotype was veriﬁed by reisolating
these colonies on plates containing the same medium (Fig. S1). In total, three of the
isolated strains grew signiﬁcantly faster than the parent strain at low peptide concen-
trations.
To identify possible reasons for the improved growth of the isolated strains,
genomic DNA was prepared and analyzed by next-generation sequencing. A compar-
ison of the genomic sequences of the mutant and the parent strains revealed that all
three mutant strains had acquired mutations in the gene dppA, encoding the periplas-
mic binding protein of dipeptide permease, which had been shown to be responsible
for the uptake of Ala--Glu-Leu. One strain had a point mutation at amino acid position
268, causing an amino acid change from serine to leucine (DppA S268L). The other two
strains had duplications of residues D395 (DppA D395dup) and T418 (DppA T418dup),
respectively. No additional mutations were identiﬁed in these strains or the pPnGGT
plasmids isolated from these strains.
In vivo characterization of DppA variants. To further investigate the impact of the
adaptive dppAmutations, a wild-type dppA gene was cloned into the low-copy-number
vector pSEVA271 under the control of a tetracycline-inducible promoter, resulting in
plasmid pSEVA271/dppA, and the identiﬁed dppA mutations were introduced by site-
directed mutagenesis. The inﬂuence of dppA overexpression was analyzed in strain
TK070/pPnGGT additionally transformed with the dppA expression plasmids, and
growth was tested in liquid M9 minimal medium supplemented with glucose and with
various concentrations of the peptide Ala--Glu-Leu. At 0.1 mM Ala--Glu-Leu, no
growth was detected if the strain was transformed with the empty vector pSEVA271 or
plasmid pSEVA271/dppA containing the dppA wild-type gene (Fig. 1c; also see Table S1
in the supplemental material). If, however, wild-type DppA was replaced by the S268L
or D395dup mutant variant, growth was observed at this peptide concentration. The
fastest growth was observed when the S268L D395dup double mutant was synthe-
sized, indicating a combinatorial effect of the two mutations in dppA. Similar results
were obtained at a concentration of 0.25 mM Ala--Glu-Leu. Here, all strains that
synthesized DppA mutant variants were able to grow, and no signiﬁcant differences
between these strains were observed (Fig. 1d and Table S1). At 0.5 mM Ala--Glu-Leu,
all strains synthesizing the DppA mutant variants grew rapidly, while only residual
growth was detected if the strain was transformed with the empty vector pSEVA271 or
plasmid pSEVA271/dppA (Fig. 1e and Table S1). This residual growth was presumably
observed because of the continuing presence of the endogenous dipeptide permease
components that were still encoded on the chromosome of strain TK070. Initially,
we attempted to perform growth experiments in dppA or dppABCDF deletion strains.
However, deleting dppA turned out to lead to polar effects on other genes of the dpp
operon. Deleting the entire dpp operon and expressing all transporter components
from a plasmid, on the other hand, led to a severe reduction in cell viability. Therefore,
we chose the strategy in which we overexpress only dppA from a plasmid and thereby
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outcompete the endogenous DppA variant. The signiﬁcant differences in growth
between strains synthesizing wild-type DppA and DppA mutant variants indicate that
this strategy was valid. Improved growth at low peptide concentrations was also
observed when synthesizing DppA T418dup, but this mutant was not further analyzed
due to its detrimental effect on protein stability (see below). Taken together, these data
indicate that the mutations identiﬁed in dppA led to improved uptake of Ala--Glu-Leu
at low peptide concentrations. Similar experiments in strain TK071 (ΔdppABCDF) con-
ﬁrmed that the beneﬁcial effects of the DppA mutant variants only occur if all
components of the dipeptide permease are present (Fig. S2).
The results obtained until this point raised the question if the identiﬁed dppA
mutations speciﬁcally improved utilization of the peptide Ala--Glu-Leu or if peptides
containing other cargo molecules attached to the glutamate side chain would be
affected as well, which would greatly contribute to the generality of the synthetic
transport system. To investigate this, similar growth assays were performed with the
peptide Ala--Glu-Phe-Leu (Fig. 1a, peptide 2). Due to the additional phenylalanine
residue attached to the glutamate side chain, the cargo load of this peptide differs
considerably in size and structure from the cargo load of the peptide Ala--Glu-Leu, but
it still offers the possibility to select for growth with a leucine auxotrophic selection
strain. Therefore, strain TK070 harboring pPnGGT and the same derivatives of pSEVA271/
dppA was grown in liquid M9 minimal medium supplemented with 2 mM Ala--Glu-
Phe-Leu, and results were obtained comparable to those with Ala--Glu-Leu (Fig. 1f and
Table S1). Strains synthesizing the DppA mutant variants S268L and S268L D395dup
grew signiﬁcantly faster in this medium than strains carrying an empty vector or
synthesizing wild-type DppA, while the strain synthesizing the DppA D395dup mutant
variant grew only slightly faster than the controls. However, it has to be noted that the
required concentration of Ala--Glu-Phe-Leu in the growth medium was higher than
that in the experiments with Ala--Glu-Leu. The two most likely explanations for this
increased demand for Ala--Glu-Phe-Leu were either reduced transport of the peptide
into the cell or inefﬁcient hydrolysis of the intracellular cleavage product -Glu-Phe-Leu
by PnGGT.
To analyze the hydrolysis of this cleavage product by PnGGT, the kinetic parameters
of PnGGT were determined with the substrates -Glu-Leu and -Glu-Phe-Leu. The
measurements revealed that PnGGT has a 9.2-fold lower Km for -Glu-Leu than for
-Glu-Phe-Leu and a 3-fold higher Vmax for -Glu-Leu than for -Glu-Phe-Leu, resulting
in an approximately 27-fold higher catalytic efﬁciency (kcat/Km) of PnGGT for -Glu-Leu
(Table 1 and Fig. S3a and b). These ﬁndings indicate that slower growth on Ala--Glu-
Phe-Leu can be explained at least in part by less efﬁcient enzymatic release of the cargo
Phe-Leu by PnGGT. At the same time, the mutations identiﬁed in dppA seem to improve
growth on peptides containing cargo molecules that vary markedly in size and struc-
ture, suggesting that these ﬁndings can potentially be transferred to future applications
of the transport system.
Synthesis and puriﬁcation of DppAmutant variants. Faster utilization of peptides
containing -glutamyl amides by strains synthesizing DppA mutant variants can po-
tentially be explained by improved afﬁnity of the DppA mutant variants for these
peptides. Improved binding might lead to enhanced delivery of peptides to the
TABLE 1 Kinetic measurements with puriﬁed PnGGT and the substrates -Glu-Leu and
-Glu-Phe-Leu
Measurement -Glu-Leu -Glu-Phe-Leu
Km (M) (mean  SD)a 145.1 27.6 1,335 303
Vmax (mean  SD) (mol · min1 · mg1)a,b 24.7 1.39 8.41 0.765
kcat (s1)c 24.4 8.31
kcat/Km (mM1 · s1) 168 6.22
aCalculated from triplicate measurements.
bThe reaction curves are shown in Fig. S3.
cValues were calculated from the mean values for Vmax.
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transmembrane proteins DppB and DppC and ultimately result in improved uptake and
faster growth at low peptide concentrations (19). To test this hypothesis, DppA variants
were puriﬁed in their open unliganded conformations, and their binding afﬁnities for
different peptides were investigated in vitro. To facilitate the puriﬁcation of DppA,
genes harboring the respective mutations were cloned into the expression vector
pET30b, generating C-terminal 8His tag fusions. It was previously reported for the
homologous periplasmic binding protein OppA from E. coli that fusion to a C-terminal
8His tag does not affect the binding afﬁnity of the protein for peptide ligands or its
solubility (26). The feasibility of this approach for DppA was further supported by the
high degree of structural similarity between OppA and DppA (root mean square
deviation [RMSD], 2.051 Å over 395 aligned residues; 25.8% sequence identity [27]).
DppA and the S268L and D395dup mutant variants were efﬁciently synthesized in
E. coli strain BL21(DE3) and were detectable by SDS-PAGE (Fig. S4a). The T418dup
mutant variant was synthesized at much lower levels, presumably due to reduced
stability of the protein (see below). Of the double mutants, only the S268L D395dup
variant was efﬁciently synthesized, while the S268L T418dup and D395dup T418dup
variants were hardly detectable by SDS-PAGE. Puriﬁcation of DppA variants by immo-
bilized metal afﬁnity chromatography resulted in highly pure protein fractions (Fig.
S4b).
Thermal shift assays with DppA variants. To analyze the thermostabilities of the
DppA variants in more detail and to get a ﬁrst indication of their binding afﬁnities
toward peptides, thermal denaturation midpoint shift (Tm shift) assays were performed.
In this assay, the apparent midpoint melting temperature (Tm) of thermal denaturation
for a protein is determined in the presence and absence of a ligand. Preferential
binding of a ligand to the native state of a protein often results in stabilization of the
protein by mass action. The difference in Tm between unbound and bound states of a
protein (ΔTm) is often well correlated with binding afﬁnity for ligands binding in the
same site with the same binding mode (28). The two ligands tested in these assays were
the peptides Ala--Glu-Leu and Ala--Glu-Phe-Leu, which had been used in the previ-
ous growth experiments. In the presence of each peptide, the Tm of wild-type DppA
was increased, indicating that both peptides bind to the wild-type protein (Table 2 and
Fig. 2). All three DppA single mutants were thermally destabilized with respect to the
wild-type protein (lower Tm) but exhibited larger ΔTm values in the presence of either
peptide, indicating tighter binding. The largest reduction in Tm of 20.5°C was observed
for the T418dup mutant, which also gave the highest ΔTm values in the presence of
peptide. For the S268L D395dup double mutant, a2-fold higher ΔTm was detected for
both peptides than for the DppA wild type, demonstrating improved binding of
peptides containing -substituted glutamate residues to this mutant. The S268L
T418dup and D395dup T418dup double mutants were hard to purify in sufﬁcient yield
and showed no clear denaturation transition or visible precipitate in the tube in the Tm
shift assay, and attempts to obtain Tm values by thermal denaturation experiments
monitored by circular dichroism spectroscopy were hampered by aggregation. Thus,
these double mutants were deemed too unstable for further analysis.
Isothermal titration calorimetry of DppA variants. Isothermal titration calorime-
try (ITC) measurements were performed to quantify the binding afﬁnities of DppA
TABLE 2 Thermal shift assays with DppA wild type and mutantsa
DppA wild
type or mutant
Tm (°C),
unbound Tm (°C), Ala--Glu-Leu Tm (°C), Ala--Glu-Phe-Leu
DppA 70.5 0.1 2.4 0.1 2.0 0.1
D395dup 62.0 0.1 3.1 0.1 2.8 0.1
S268L 60.5 0.1 3.3 0.2 4.7 0.2
T418dup 50.0 0.2 4.5 0.2 6.7 0.2
S268L D395dup 54.4 0.1 5.8 0.2 5.3 0.2
aMeasurements were performed in triplicate with 4 M protein and 2.5 mM peptide. Values are represented
as mean  standard deviation.
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variants for the two peptide ligands Ala--Glu-Leu and Ala--Glu-Phe-Leu (Table 3). The
signal-to-noise ratio in ITC experiments is dependent on the enthalpy change for
binding (ΔH), which varies with temperature for interactions with nonzero changes in
heat capacity and on the amount of ligand that is bound in each injection. Many of the
interactions of the peptides with DppA variants were relatively weak in afﬁnity and low
in ΔH, so it was necessary to maximize the signal-to-noise ratio by using higher protein
and ligand concentrations and choosing an experimental temperature where the
magnitude of ΔH was relatively large for each variant. At the same time, the choice of
experimental temperature was limited by the thermal stability of the variants, partic-
ularly the less-thermostable mutants T418dup and S268L D395dup, for which experi-
ments were performed only at or below 25°C, outside the region of the thermal
denaturation transition. These factors meant that it was not possible to identify a
common measurement temperature for all mutants, nor was it possible to measure ΔH
accurately at a sufﬁcient range of temperatures to obtain the change in heat capacity
for binding, so a detailed and unambiguous comparison of thermodynamic parameters
FIG 2 The ﬁrst derivative of the ﬂuorescence emission as a function of temperature (dF/dT) from thermal
shift assays. The melt curves of wild-type DppA (black) and the mutant variant DppA S268L D395dup
(gray) are shown for the unbound proteins (solid lines), when binding to Ala--Glu-Leu (dotted lines), and
when binding to Ala--Glu-Phe-Leu (dashed lines). The Tm values are taken from the highest points of the
peaks in the derivative plot. Measurements were performed with 4.0 M protein and 2.5 mM peptide,
and the buffer was 50 mM sodium phosphate (pH 7.0).
TABLE 3 ITC measurements of DppA variants
DppA wild type or variant
by treatment KD (M)a Temp (°C) No. of expts n G (kcal/mol) H (kcal/mol)a TS (kcal/mol)
Ala--Glu-Leu
DppA 3,000b 8 1 1c 3.2 4.1 7.3
D395dup 360 37 1 1c 4.9 6.9 2.1
S268L 200 37 4 1c 5.2 4.4 0.9
T418dup 140 25 1 1c 5.3 2.2 7.4
S268L D395dup 6.4 17 1 1.0 6.9 7.0 0.1
S268L D395dup 6.8 25 1 1.1 7.0 7.7 0.7
Ala--Glu-Phe-Leu
DppA NDd ND ND ND
D395dup 650 37 2 1c 4.5 2.2 2.3
S268L 110 37 2 1c 5.6 1.5 4.1
T418dup 15 8 2 1.0 6.2 0.8 7.0
S268L D395dup 22 17 1 1.0 6.2 5.8 0.4
S268L D395dup 23 25 1 1.2 6.3 5.5 0.8
aThe standard errors for KD and ΔH are estimated at 25%, based on the multiple measurements for Ala--Glu-Leu binding to S268L and Ala--Glu-Phe-Leu binding to
S268L and T418dup, for which sufﬁcient material was available.
bThis value is an approximation based on limited data.
cn, the stoichiometric ratio is ﬁxed at 1 for the ﬁtting of weak binding peptides, as it is not adequately constrained by the data.
dND, not determined.
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was not possible. However, the observed trends can easily serve as a qualitative
measure to evaluate the effect of the dppA mutations on substrate afﬁnity.
Initial ITC experiments with nonrefolded wild-type DppA indicated that only a small
fraction of the puriﬁed protein was available for binding (15%, according to the ﬁtted
binding stoichiometry), which was assumed to be due to copuriﬁed peptides bound
to DppA. To circumvent this apparent loss of activity, an immobilized metal afﬁnity
chromatography (IMAC)-based denaturation and refolding step to remove bound
peptides was introduced. ITC experiments with the reference peptides Ala-Thr and
Ala-Leu showed that refolded His-tagged DppA exhibited a binding stoichiometry close
to the expected value of 1.0 and binding afﬁnities and thermodynamics very similar to
the values reported in literature (29), indicating that the C-terminal His tag does not
affect binding of the ligand and that the refolded protein is functional (Table S2).
Wild-type DppA bound Ala--Glu-Leu only weakly, with a dissociation constant (KD)
of approximately 3 mM (Table 3). The three DppA single mutants had higher afﬁnities
toward Ala--Glu-Leu, as indicated by 9- to 22-fold reduction in the KD value, in
agreement with the results from the thermal shift assays. The highest binding afﬁnity
toward Ala--Glu-Leu was measured for the S268L D395dup double mutant, resulting
in a KD value of 6 M, constituting an approximately 500-fold improvement in afﬁnity
compared to wild-type DppA. Representative ITC data showing the improvement in
afﬁnity for the DppA S268L and S268L D395dup variants are shown in Fig. 3.
In the case of the peptide Ala--Glu-Phe-Leu, binding to wild-type DppA was
apparently too weak to measure, but afﬁnity was again improved upon mutation,
resulting in KD values of around 20 M for variants T418dup and S268L D395dup,
approximately 7-fold stronger and 3-fold weaker than the respective afﬁnities of these
variants for Ala--Glu-Leu. Given that the enthalpy of ionization for phosphate buffer is
relatively small at the experimental temperatures used, meaningful comparisons of
binding enthalpy can be made for measurements at the same temperature. For all
mutants where such a comparison could be made, the binding of Ala--Glu-Phe-Leu
was less enthalpically favorable (less-negative ΔH) but more entropically favorable
(more-positive TΔS) than the binding of Ala--Glu-Leu, probably reﬂecting the in-
creased contribution of hydrophobic interactions in the binding of the phenylalanine-
containing ligand.
FIG 3 ITC measurements of Ala--Glu-Leu binding to DppA and mutant variants. The upper plots show the differential power
versus time for binding reactions upon sequential injections of Ala--Glu-Leu into protein. These data were integrated and
normalized to give the heat changes for each injection in kilocalories per mole peptide injected, which are shown as a function
of molar ratio (peptide/protein) in the lower plots. The solid lines in the lower plots show the best ﬁt to the data using the One
Set of Sites binding model in Origin for ITC. Injections are Ala--Glu-Leu (5 mM) into the DppA (97.5 M)-containing sample at
8°C (a), Ala--Glu-Leu (5 mM) into the DppA S268L (105 M)-containing sample at 37°C (b), and Ala--Glu-Leu (0.54 mM) into the
DppA S268L D395dup (44.2 M)-containing sample at 17°C (c). The buffer was 50 mM sodium phosphate (pH 7.0) in all cases.
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These ﬁndings showed that the size and structure of the cargo molecule attached
to the glutamate side chain seem to have only a small impact on the binding
efﬁciencies of peptides to these DppA mutant variants, which together with the less
efﬁcient hydrolysis of the cleavage product -Glu-Phe-Leu by PnGGT explains the
higher Ala--Glu-Phe-Leu concentrations needed for growth of the leucine auxotrophic
selection strain.
Uptake of phosphorylated cargo molecules. Finally, we wondered whether
the changes in DppA that improved transport of bulky molecules, such as Ala--Glu-
Phe-Leu, might coincidentally also improve uptake of heavily negatively charged
molecules, such as phosphorylated cargo molecules. For that, the threonine biosyn-
thesis pathway intermediate O-phospho-L-homoserine (PHS) and the noncanonical
amino acid O-phospho-L-serine (SEP), which can be site-speciﬁcally incorporated into
proteins to study the effects of protein phosphorylation (30), were attached to the
glutamate side chain of the peptide Ala-Glu (Fig. 1a, peptides 3 and 4). Unfortunately,
simultaneous synthesis of PnGGT and a DppA wild type or mutant variant in the
threonine auxotrophic strain TK074 did not restore growth of this strain in minimal
medium supplemented with 2 mM Ala--Glu-PHS. Subsequent thermal shift assays with
wild-type DppA and the DppA D395dup mutant revealed only minimal binding of the
two peptides containing the phosphorylated cargo molecules to the DppA variants
(Fig. S5). These results indicate that uptake of the two peptides is most likely prevented
by insufﬁcient recognition by DppA and that new DppA variants would need to be
evolved to expand import to such molecules.
DISCUSSION
In this study, three mutant variants of the periplasmic substrate-binding protein
DppA were identiﬁed that led to improved utilization of peptides containing -sub-
stituted glutamate residues. These peptides are of particular interest, as they can be
used as transport vectors in a previously described synthetic transport system (9). This
system provides a novel way to make compounds available in the cytoplasm of E. coli
that are otherwise not taken up by the cell, thereby offering a valuable tool for
metabolic engineering and synthetic biology approaches.
DppA is part of the dipeptide permease transport system that was shown by
mutational studies to be responsible for the uptake of the peptide Ala--Glu-Leu.
Thermal denaturation midpoint shift assays and isothermal titration calorimetry re-
vealed that all three mutations that were identiﬁed in DppA signiﬁcantly increased the
afﬁnity for the peptides Ala--Glu-Leu and Ala--Glu-Phe-Leu, leading to improved
uptake and eventually faster growth on these substrates, but not for the phosphory-
lated peptides Ala--Glu-PHS and Ala--Glu-SEP. In general, DppA is known to be more
restrictive toward side-chain modiﬁcations of its peptide substrates than the SBP OppA
of the oligopeptide permease transport system (23). Elucidation of the DppA crystal
structure in complex with the substrate Gly-Leu revealed that the substrate-binding site
of DppA contains two pockets, a larger pocket accommodating the side chain of the
N-terminal amino acid, and a smaller pocket accommodating the side chain of the
C-terminal amino acid of a peptide substrate (21). The smaller size of the second pocket
might explain the lower tolerance of wild-type DppA for side-chain modiﬁcations in
general and the low afﬁnity for peptides containing -glutamyl amides in this position
in particular. The crystal structure of wild-type DppA also revealed that the smaller
pocket is delineated by residues Thr20, Ser21, Trp386, Tyr389, Leu390, Met403, Trp405,
Ser429, and Tyr431. Interestingly, the two amino acid insertions in the identiﬁed DppA
variants are duplications of residues Asp395 and Thr418 and therefore lie in the same
domain and in close proximity to most of the residues delineating the pocket that
accommodates the -substituted glutamate residue (Fig. S6). These ﬁndings suggest
that the insertions might lead to conformational changes that facilitate the binding of
-glutamyl amides in this pocket. Residue Ser268, on the other hand, is part of strand
5-III, a -sheet that is antiparallel to strand 3-III, which is, again, antiparallel to the
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peptide ligand and strongly involved in its binding. Therefore, mutation S268L might,
although indirectly, inﬂuence the binding of certain peptide ligands.
Our results indicate that the tolerance of DppA for certain side-chain modiﬁcations
can be signiﬁcantly increased by introducing point mutation S268L or duplicating
residues D395 or T418. These ﬁndings are consistent with the assumption that for the
Dpp system, the SBP of the ABC transporter primarily determines the speciﬁcity of the
entire transporter, as is the case for other ABC transporters as well (15, 19, 20, 31, 32).
To grow a leucine auxotrophic selection strain on minimal medium containing Ala--
Glu-Phe-Leu, higher peptide concentrations were required than for minimal medium
containing Ala--Glu-Leu. It is likely that slower growth on Ala--Glu-Phe-Leu is largely
attributable to less efﬁcient hydrolysis of -Glu-Phe-Leu by PnGGT after transport, as
consistent with kinetic measurements with puriﬁed PnGGT. This ﬁnding offers the
potential to further improve the synthetic transport system in future work by broad-
ening the substrate speciﬁcity of PnGGT by directed evolution. Other possible expla-
nations for the inefﬁcient utilization of Ala--Glu-Phe-Leu include impaired removal of
the N-terminal alanine residue to make -Glu-Phe-Leu available for PnGGT or slower
hydrolysis of Phe-Leu by the peptidases of E. coli. The ﬁnding that peptides containing
phosphorylated cargo molecules were not sufﬁciently bound by DppA can be ex-
plained by the small size of the second DppA binding pocket or, more likely, by the
negative charge of the attached phosphate group. Accommodating the negative
charges in the rather narrow binding pocket of DppA would presumably require more
extensive restructuring of the binding pocket, which was unlikely to be achieved with
the selection strategy that was used to identify the DppA mutant variants described in
this study.
A comparison of ITC data with previously published values for the interaction of
dipeptides with wild-type DppA shows that the strongest afﬁnity achieved in this study
for variant S268L D395dup with the peptide Ala--Glu-Leu (7 M, ΔH 7.7 kcal/mol at
25°C) is comparable to that observed for the weakest binding standard dipeptide
studied previously with wild-type DppA (6 M, ΔH 10.3 kcal/mol) (29). The fact that
the binding is less enthalpically favorable but more entropically favorable for variant
S268L D395dup can presumably be explained by the displacement of additional water
by the larger and more hydrophobic ligand. The majority of dipeptides studied showed
signiﬁcantly higher afﬁnity for DppA (in the nM range) and more exothermic enthalpies
of binding, evincing the evolutionary optimization of the whole binding site for
dipeptide binding.
Two out of the three DppA mutant variants we identiﬁed resulted from the
duplication of single codons, presumably introduced by replication slippage (33),
demonstrating that the introduction of insertions can be a valid approach to improve
protein function. Even though we cannot exclude that a similar effect might have been
achieved without duplication by saturation mutagenesis of one or several amino acid
residues at the site of the duplicated codon, we can state that extension resulted as a
suitable outcome that would have been difﬁcult to achieve with other standard
directed evolution methods, such as error-prone PCR, as these do not address the
length of a sequence. Only recently, a directed evolution method for the generation of
libraries that vary both in sequence and length was developed, which could have
potentially produced similar mutations (34).
Taken together, our data demonstrate that the afﬁnity of an ABC transporter for a
ligand can be signiﬁcantly improved by mutating the substrate-binding protein of the
transporter. This ﬁnding greatly improves the efﬁciency and applicability of the PnGGT-
based synthetic transport system and additionally offers the potential to improve
previous peptide-based approaches to overcome transport problems (3, 5–8).
MATERIALS AND METHODS
Strains and media. All bacterial strains used in this study are listed in Table 4. For cloning purposes,
E. coli strain DH5 pir was used. The dppABCDF and oppABCDF operons were deleted by plasmid-based
gene replacement (35, 36). For this, two 500-bp fragments ﬂanking the respective operon were ampliﬁed,
combined by PCR, and cloned into plasmid pEMG via EcoRI and BamHI (both New England BioLabs,
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Ipswich, MA, USA) restriction sites. For the construction of strains TK060 and TK074, the ggt, pcnB, and
thrB genes were replaced with disrupted versions by P1 phage transduction using the respective donor
strains from the KEIO collection (37, 38).
Bacterial cultures were grown in LB Miller broth (Becton Dickinson, Sparks, MD, USA) or super optimal
broth (SOB) medium as standard growth media (39, 40). Growth experiments in selective medium were
carried out in M9 minimal medium (40) containing 0.5% glucose and different concentrations of the
peptides alanyl--glutamyl-leucine (Ala--Glu-Leu), alanyl--glutamyl-phenylalanyl-leucine (Ala--Glu-
Phe-Leu), and alanyl--glutamyl-PHS, as described previously (9). Ala--Glu-Leu and Ala--Glu-Phe-Leu
were custom synthesized by Pepscan (95% purity; Lelystad, The Netherlands). For the preparation of
solid medium, Bacto agar (Becton Dickinson) was added to a ﬁnal concentration of 1.5%. Antibiotics were
added to all media to obtain the following concentrations: kanamycin, 50 g · ml1; chloramphenicol,
34 g · ml1; gentamicin, 10 g · ml1; and carbenicillin, 100 g · ml1.
Chemical synthesis of Ala--Glu-PHS and Ala--Glu-SEP. The benzyl-protected phosphoserine
methyl ester hydrochloride molecule 6 or its phosphohomoserine congener molecule 7 were coupled
with peptide 5 using O-benzotriazole-N,N,N=,N=-tetramethyluronium hexaﬂuorophosphate (HBTU) as the
coupling agent (Fig. 4). This provided us with the fully protected dipeptides 8 and 9 in good yields.
Peptide 8 was initially subjected to ester hydrolysis to cleave the methyl esters. Subsequent N-terminal
deprotection followed by catalytic hydrogenation provided us with a dephosphorylated peptide. We
next tried to deprotect the phosphate group after ester hydrolysis but before carbamate deprotection
and again obtained, as the sole product, a peptide in which the phosphate group had been cleaved.
TABLE 4 Strains used in this study
E. coli strain Description
Reference(s) or
source
DH5 pir supE44 ΔlacU169 (80lacZΔM15) hsdR17 (rK mK) recA1 endA1 thi-1 gyrA
relA lysogenic pir
50
JM101 glnV44 thi-1 Δ(lac-proAB) F=[lacIqZΔM15 traD36 proAB] 51, 52
BL21(DE3) E. coli strain B F ompT gal dcm lon hsdSB(rB mB) (DE3 [lacI lacUV5-T7p07
ind1 sam7 nin5]) [malB]K-12(S)
53
JW0002 BW25113 thrB::kan 37
TK060 JM101 Δggt ΔpcnB This study
TK070 (TK054 ΔpcnB) JM101 ΔleuB Δggt Δliv ΔbrnQ ΔpcnB 9
TK071 TK070 ΔdppABCDF This study
TK072 TK070 ΔoppABCDF This study
TK073 TK070 ΔdppABCDF ΔoppABCDF This study
TK074 TK060 ΔthrB This study
FIG 4 Synthesis scheme for Ala--Glu-SEP (peptide 3) and Ala--Glu-PHS (peptide 4). The Materials and Methods section contains
a detailed description of the synthesis routes.
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Phosphate deprotection with the methyl ester still in place, however, gave us the phosphorylated
peptide in good yield. It seems that the alpha-carboxylate of the serine residue is involved in the
phosphate ester hydrolysis during catalytic hydrogenation wherein the carboxylate attacks the phos-
phate center structure resulting in dephosphorylation. This hypothesis is supported by the results
obtained during deprotection of peptide 3. The -benzyl ester and the benzyl phosphates can be easily
deprotected in one-pot hydrogenation. In this case (peptide 9), a good yield of completely deprotected
peptide 4 was obtained after acid hydrolysis of carbamate and ester cleavage of glutamate. Thereafter,
peptide 8 was ﬁrst subjected to acid, followed by hydrogenation and then ester deprotection to obtain
phosphorylated peptide 3. After complete deprotection, the peptides were puriﬁed on a reverse-phase
high-performance liquid chromatogram (RP-HPLC; water-acetonitrile–0.1% triﬂuoroacetic acid [TFA]) to
obtain peptides 3 and 4 as white solids in triﬂuoroacetate form.
The reagents and conditions used were (i) dry dimethylformamide (DMF), HBTU, and N,N-
diisopropylethylamine (DIPEA) at 0°C to room temperature (r.t.) overnight; (ii) 50% TFA in DCM for 8 h,
followed by 10% Pd(0)/C and H2O:CH3OH at 1:1 in H2 overnight; (iii) LiOH and H2O:CH3OH at 1:1
overnight, with the reaction quenched with CH3COOH; (iv) 10% Pd(0)/C, H2O:CH3OH at 1:1, and H2
overnight; and (v) 50% TFA in DCM for 8 h, followed by LiOH and H2O:CH3OH at 1:1 overnight, with the
reaction quenched with CH3COOH.
All moisture-sensitive reactions were performed under a nitrogen atmosphere. Dry solvents were
purchased from commercial sources and used as such. Reactions were monitored by thin-layer chroma-
tography (TLC; precoated silica gel plate F254; Merck Millipore, Billerica, MA, USA). Flash chromatography
was done on Merck Kieselgel 60 (230 to 400 mesh). 1H, 13C, and 31P spectra were recorded on nuclear
magnetic resonance (NMR) spectrometers operating at 300 MHz, 75 MHz, and 121 MHz, respectively (see
the supplemental material).
DNA constructs. For cloning purposes, DNA fragments were ampliﬁed using Phusion high-ﬁdelity
DNA polymerase (New England BioLabs). Derivatives of plasmids pEMG and pET30b were constructed by
conventional cloning using restriction enzymes and a Quick Ligation kit (all New England BioLabs).
Derivatives of plasmid pSEVA271 were constructed by Gibson Assembly (New England BioLabs) using the
vector backbone of pSEVA271, the Ptet-PT7 fusion promoter from plasmid pAB92, and the dppA gene
ampliﬁed from chromosomal E. coli DNA. DNA constructs were veriﬁed by Sanger sequencing (Mi-
crosynth, Balgach, Switzerland) and are summarized in Table 5. The oligonucleotides used for construc-
tion are listed in Table 6.
Protein synthesis and puriﬁcation. To synthesize PnGGT in strain JM101 and the DppA variants in
BL21(DE3), cells carrying the respective plasmids were grown in LB medium to an optical density at 600
nm (OD600) of approximately 0.5 and induced with 0.5 mM IPTG. Following an expression period (20 h,
20°C), cells were harvested by centrifugation, resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl,
10 mM imidazole, 1 mg · ml1 lysozyme [pH 8.0]), incubated for 30 min on ice, and then frozen at 80°C
for at least 30 min. After thawing and subsequent centrifugation, the supernatant containing the soluble
protein fraction was collected.
His-tagged PnGGT was puriﬁed by immobilized metal afﬁnity chromatography (IMAC) using nickel-
nitrilotriacetic acid (Ni-NTA) Superﬂow (Qiagen, Hilden, Germany), as described previously (41). Fractions
containing puriﬁed PnGGT were dialyzed against 50 mM Tris-HCl (pH 7.0). To obtain DppA variants in
TABLE 5 Plasmids used in this study
Plasmid Descriptiona Reference or source
pACT3 Expression vector; pLlacO1 p15A ori Cmr lacIq 54
pSEVA271 MCS; pSC101 ori Kanr 55
pAB92 SEVA vector backbone; MCS, pBR322 ori Ampr, Ptet-PT7 fusion promoter 56
pET30b T7 promoter; MCS; pBR322 ori, Kanr Novagen (Madison,
WI, USA)
pEMG Delivery vector for plasmid-based gene replacement; oriR6K lacZ, ﬂanking I-SceI
sites, Kanr
35
pParaI-SceI I-SceI gene under the control of L-arabinose-inducible promoter; p15A ori, Gmr 57
pPnGGT (pACT3/6His_ PnGGT ΔN24) PnGGT ΔN24 gene with N-terminal MRGSHHHHHHGSACEL cloned in pACT3 9
pEMG-dppABCDF pEMG bearing a 1.0-kb TS1-TS2 EcoRI-BamHI insert for deleting dppABCDF This study
pEMG-oppABCDF pEMG bearing a 1.0-kb TS1-TS2 EcoRI-BamHI insert for deleting oppABCDF This study
pSEVA271/dppA pSEVA271 backbone with Ptet-PT7 fusion promoter fragment from pAB92 and
dppA gene
This study
pSEVA271/dppA_S268L pSEVA271/dppA with S268L mutation This study
pSEVA271/dppA_D395dup pSEVA271/dppA with duplication of residue D395 This study
pSEVA271/dppA_S268L_D395dup pSEVA271/dppA with S268L mutation and duplication of residue D395 This study
pET30b/dppA pET30b containing dppA gene with C-terminal 8His tag pET30b This study
pET30b/dppA_S268L pET30b/dppA with S268L mutation This study
pET30b/dppA_D395dup pET30b/dppA with duplication of residue D395 This study
pET30b/dppA_T418dup pET30b/dppA with duplication of residue T418 This study
pET30b/dppA_S268L_D395dup pET30b/dppA with S268L mutation and duplication of residue D395 This study
pET30b/dppA_S268L_T418dup pET30b/dppA with S268L mutation and duplication of residue T418 This study
pET30b/dppA_D395dup_T418dup pET30b/dppA with duplication of residue D395 and duplication of residue T418 This study
aCmr, chloramphenicol resistance; Kanr, kanamycin resistance; MCS, multicloning site; Ampr, ampicillin resistance; Gmr, gentamicin resistance.
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their open unliganded conformation, proteins were immobilized on a column containing Ni-NTA
Superﬂow and were partly denatured and refolded by washing with washing buffer (50 mM 4-morpho-
lineethanesulfonic acid, 300 mM NaCl, and 20 mM imidazole [pH 8] containing decreasing concentrations
of guanidinium hydrochloride [4 column volumes {CV} of 2 M, 4 CV of 1.5 M, 4 CV of 1 M, 4 CV of 0.5 M,
and 10 CV of buffer without guanidinium hydrochloride]) (26). The refolded protein was eluted in 7 steps
with elution buffer (50 mM 4-morpholineethanesulfonic acid, 300 mM NaCl, and 500 mM imidazole [pH
6]). Subsequent to puriﬁcation, fractions containing DppA variants were dialyzed three times against a
1,000-fold excess of 50 mM sodium phosphate buffer (pH 7.0) and ﬁltered using Millex-GV 0.22-m-
pore-size polyvinylidene diﬂuoride (PVDF) syringe ﬁlters (Merck Millipore) to remove larger particles. The
concentrations of DppA variants were determined by UV absorption at 280 nm with an HP 8453 UV
spectroscope (Hewlett-Packard, Palo Alto, CA, USA), by using the calculated molar extinction coefﬁcient
() of 89,980 M1 · cm1 (42). All protein samples were analyzed by SDS-PAGE, as reported previously
(43).
Kinetic measurements with PnGGT. To determine the kinetic properties of PnGGT, appropriate
amounts of puriﬁed protein were preincubated at 37°C in 50 mM Tris-HCl (pH 7.0). To start the reaction,
the substrate -Glu-Leu (Bachem, Bubendorf, Switzerland) or -Glu-Phe-Leu (custom synthesized to
95% purity, Pepscan, Lelystad, Netherlands) was added at the indicated concentrations. The reaction
was stopped at different time points by mixing 100 l of the reaction mix with 100 l of 50 mM Tris-HCl
(pH 7.0) preheated to 95°C and shaking at 600 rpm. After 5 min of incubation at 95°C, the samples were
centrifuged at 4°C and 21,130  g to remove the denatured protein. The supernatant was diluted in 50
mM Tris-HCl (pH 7.0) as necessary, and the glutamate concentration was determined using a commercial
enzyme assay (glutamate assay kit [ﬂuorometric]; Abcam, Cambridge, United Kingdom). Data from
measurements were analyzed using SigmaPlot 12.2 (Systat, San Jose, CA, USA).
Thermal shift assay. The thermal denaturation midpoint melting temperature (Tm) of DppA wild-
type protein and variants was determined by monitoring the ﬂuorescence intensity of Sypro Orange dye
in the absence/presence of peptides as a function of temperature. Protein was mixed with 1 Sypro
Orange from Thermo Fisher Scientiﬁc (Waltham, MA, USA) in 50 mM sodium phosphate (pH 7.0). The
experiments were performed with a real-time PCR system (Rotor-Gene Q; Qiagen, Hilden, Germany) with
a temperature ramp from 25 to 95°C, using a ramp rate of 5.3°C · min1 and a reaction volume of 40 l.
The ﬁrst derivative of the ﬂuorescence intensity curve was calculated in order to determine the midpoint
melting temperature (Tm) for proteins with and without bound peptides.
Isothermal titration calorimetry. ITC was performed using the MicroCal ITC-200 instrument
(Malvern Instruments, Worcestershire, UK). The cell volume was 200 l, and each injection volume was
2 l. Peptide and protein concentrations were chosen for each mutant and peptide to give data suitable
for accurate KD determination. All measurements were conducted in 50 mM sodium phosphate (pH 7.0)
as a buffer. Solutions were degassed under a vacuum for 10 min prior to the experiments. Peptide
solutions in the injection syringe were titrated into the calorimeter cell-containing protein solutions, and
the heat ﬂow caused by protein-peptide interaction was recorded and analyzed by the software provided
with the instrument. The quantitative interpretation of the binding isotherm was performed with the
“One Sets of Sites” binding model in the MicroCal Origin software (OriginLab, Northampton, MA, USA).
Genome sequencing of mutant strains. In order to prepare chromosomal DNA for resequencing,
genomic DNA was puriﬁed with the High Pure PCR template preparation kit (Roche Diagnostics, Basel,
Switzerland). Sequencing libraries were prepared using TruSeq DNA sample preparation kit version 2
(Illumina, San Diego, CA, USA). These libraries were then puriﬁed using 0.7 volumes of Agencourt
AMPure XP beads (Beckman Coulter, Pasadena, CA, USA) to exclude very short library fragments. For
sequencing the puriﬁed libraries, MiSeq (Illumina) paired-end (PE) 2  301 cycles was used with the
600-cycle version 3 kit and converted to fastq ﬁles. Reads were aligned using the Bowtie 2 package (44,
45). Sequences were analyzed using the deepSNV package (46, 47) and Integrated Genome Viewer
(48, 49).
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